Skip to main content

Clitoral Pain, Priapism and Enlargement

Clitoral pain, sustained engorgement, enlargement, and focal masses have distinct structural, neurologic, vascular, and endocrine causes. Examination of the glans, prepuce, and adjacent vestibule separates many focal lesions from referred pelvic or spinal symptoms.[1]

Clitorodynia​

Clitorodynia is pain localized to the clitoris. When no identifiable disorder explains pain lasting at least three months, it fits the localized-vulvodynia terminology; pain from a visible adhesion, infection, dermatosis, cyst, neuroma, or other lesion is recorded by its cause. Pain may be provoked, spontaneous, or mixed.[1]

Retract the prepuce gently to inspect the glans and corona for adhesions, keratin pearls, debris, inflammation, or a mass. Map tenderness with a cotton swab; examine pelvic-floor tone and the pudendal course if pain is neuropathic or extends beyond the glans. Associated unwanted arousal, sitting-related pain, sensory change, or neurologic symptoms can direct pelvic, pudendal, or spinal assessment. Treat a defined local lesion or dermatosis; pelvic-floor therapy, diagnostic blocks, and specialist pain care may be appropriate when examination suggests myofascial or neuropathic pain.[1]

Clitoral Priapism​

Clitoral priapism is persistent, often painful clitoral engorgement unrelated to ongoing sexual stimulation. Review recent medications and changes, especially agents with adrenergic effects; assess the duration, pain, discoloration, trauma, and any pelvic mass or vascular finding. A reported ovarian-cancer case presented with painful clitoral enlargement and a clitoral metastasis. Published causes and treatments are largely case reports.[2][3][8]

Address a suspected medication cause and provide analgesia while evaluating persistent symptoms. In one 29-year-old patient with five days of painful engorgement after trazodone and bupropion, symptoms resolved with oral pseudoephedrine and analgesics after the suspected drugs were stopped. A separate report associated pregabalin plus duloxetine with clitoral priapism and stopped pregabalin. These reports support individualized management and escalation for persistent pain or abnormal perfusion; they do not establish a standard dose or comparative efficacy.[2][3]

Clitoral Enlargement and Apparent Enlargement​

Measure the glans and body only after identifying the prepuce, edema, and any discrete mass. Record onset, progression, medications or androgen exposure, prior genital surgery or trauma, and associated virilization. A focal cyst can create pseudoclitoromegaly without enlargement of the erectile body.[4][5]

Rapid progression, new virilization, or onset after menopause warrants prompt endocrine evaluation for ovarian or adrenal androgen excess. The Society for Endocrinology guideline recommends testosterone, sex hormone-binding globulin, a measure of free testosterone, androstenedione, DHEAS, 17-hydroxyprogesterone, estradiol, LH, and FSH when androgen excess is suspected. Severe biochemical excess, including testosterone above 5 nmol/L, prompts urgent ovarian and/or adrenal imaging; imaging selection follows the biochemical and clinical pattern.[4] Chronic or expected enlargement during prescribed androgen therapy is interpreted in that treatment context.

Epidermal Inclusion Cysts and Other Focal Masses​

An epidermal inclusion cyst can arise after vulvar trauma, surgery, or female genital mutilation/cutting, or without a recognized injury. It may appear as a slowly enlarging, mobile clitoral or preputial mass and can conceal the glans or mimic corporal enlargement. In Rouzi's surgical series, 29 patients with known or possible FGM/C had increasing clitoral masses; 28 underwent excision and one underwent drainage of an abscess.[5]

Ultrasound can characterize a superficial cyst; MRI defines its relationship to the corporal body, urethra, and neurovascular structures when examination is uncertain. Symptomatic or enlarging lesions may be excised with attention to the dorsal nerve and vascular supply and sent for histology. A published adult case used patient-specific sensory mapping before cyst excision to plan the incision.[6][7] An ulcerated, fixed, or atypical mass requires tissue diagnosis rather than an assumed cyst label.

For anatomy, nerve course, and imaging landmarks, see Clitoral Anatomy and Physiology.

References​

1. Krapf JM, Pope R. "Approach to diagnosis and management of clitorodynia." O G Open. 2025;2(1):e062. doi:10.1097/og9.0000000000000062

2. Unger CA, Walters MD. "Female clitoral priapism: an over-the-counter option for management." J Sex Med. 2014;11(9):2354-2356. doi:10.1111/jsm.12465

3. Nguyen J, Chin JJ, Blalock M. "Probable drug-induced clitoral priapism due to potentiating effects of pregabalin and duloxetine." Am J Health Syst Pharm. 2023;80(1):e14-e17. doi:10.1093/ajhp/zxac257

4. Elhassan YS, Hawley JM, Cussen L, et al. "Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women." Clin Endocrinol (Oxf). 2025;103(4):540-566. doi:10.1111/cen.15265

5. Rouzi AA. "Epidermal clitoral inclusion cysts: not a rare complication of female genital mutilation." Hum Reprod. 2010;25(7):1672-1674. doi:10.1093/humrep/deq126

6. Golden E, Cooke S, Butler E, Gregg L, Gomez E. "Under the hood: vulvar anatomy and pathology with a focus on MRI." Abdom Radiol (NY). 2026;51(4):2106-2124. doi:10.1007/s00261-025-05179-1

7. Wu C, Damitz L, Karrat KM, Mintz A, Zolnoun D. "Clitoral epidermal inclusion cyst resection with intraoperative sensory nerve mapping technique." Female Pelvic Med Reconstr Surg. 2016;22(3):e24-e26. doi:10.1097/SPV.0000000000000267

8. Schneiter MK, Stany MP. "Clitoral priapism due to distant clitoral metastasis of high-grade serous ovarian carcinoma: a case report and review of the literature." Gynecol Oncol Rep. 2018;24:99-101. doi:10.1016/j.gore.2018.04.011